Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a prominent pharmaceutical company specializing in the production and distribution of heparin and related products. Heparin, a critical anticoagulan... Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a prominent pharmaceutical company specializing in the production and distribution of heparin and related products. Heparin, a critical anticoagulant, plays a vital role in medical treatments by preventing and treating blood clots. Shenzhen Hepalink is recognized for its comprehensive heparin production chain, from raw heparin sodium extraction to various formulated products, thereby ensuring high quality and consistency. The company extends its influence across diverse healthcare sectors, impacting hospitals, clinics, and other medical institutions worldwide. Headquartered in Shenzhen, China, it capitalizes on advancements in biotechnology and compliance with international health standards to maintain its competitive edge. By leveraging strong research and development initiatives, Shenzhen Hepalink contributes significantly to the pharmaceutical industry, driving innovation in anticoagulant therapies while expanding its market presence globally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Hepalink is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Hepalink is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Hepalink's data?

Start your 30-day free trial to request a data review for Hepalink.

Start Free Trial

Legal Center Contact Us